Skip to content
★ Sign in to follow
홍

홍성대

일신바이오
Total declarations
5
Company
1
▲ Purchases (4 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Nov 2026 for 일신바이오.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

홍성대: trading record in brief

홍성대 discloses dealings in 일신바이오 to DART (FSS). Over a trading history stretching from 23 July 2024 to 5 November 2026, the count stands at 5 filings.

Purchases make up the whole of the open-market record (4 purchases). The totals do not cover 4 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 2 purchases and no sales on the market.

Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 5 November 2026, reports an open-market purchase in 일신바이오. Filings reach the DART (FSS) feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to 홍성대

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    대표이사Executives(filed)일신바이오
    0DART
    200,000 sharesShareKRXDART:20261105000026
    Canonical exit: 3 Feb 2027 (T+90)
  • Other(filed)
    0DART
  • ▲
    대량보유자Executives일신바이오
    0DART
    537,323 sharesKRXDART:20260604000230
    Canonical exit: 2 Sept 2026 (T+90)
  • ▲
    Executives일신바이오
    0DART
    119,505 sharesKRXDART:20240725000239
    Canonical exit: 22 Oct 2024 (T+90)
  • ▲
    대표이사Executives일신바이오
    0DART
    ShareKRXDART:20240725000189
    Canonical exit: 21 Oct 2024 (T+90)

5 of 5 declarations